Clebopride
![]() | |
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.054.424 |
Chemical and physical data | |
Formula | C20H24ClN3O2 |
Molar mass | 373.88 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
Clebopride is a dopamine antagonist drug with antiemetic and prokinetic properties used to treat functional gastrointestinal disorders. Chemically, it is a substituted benzamide, closely related to metoclopramide.
A small Spanish study found that more adverse reactions are reported with clebopride than with metoclopramide, particularly extrapyramidal symptoms.[1]
References[]
- ^ Cuena Boy R, Maciá Martínez MA (March 1998). "[Extrapyramidal toxicity caused by metoclopramide and clebopride: study of voluntary notifications of adverse effects to the Spanish Drug Surveillance System]". Atencion Primaria (in Spanish). 21 (5): 289–95. PMID 9608114. Free full text
Categories:
- Antiemetics
- Dopamine antagonists
- 4-Amino-N-(3-(diethylamino)propyl)-2-methoxybenzamides
- Piperidines
- Chloroarenes
- Gastrointestinal system drug stubs